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A Review of Adult and Pediatric 
Post-Transplant Liver Pathology 
A. Jake Demetris, Ron Jaffe, and Thomas E. Starzl 
The operative techniques of liver transplantation were pioneered by Starzl in 
the 1950s and early 1960s through extensive animal experimentation. l-J Starzl 
began human orthotopic liver transplants in 1963 and has since accumulated 
vast experience in this procedure. ~-T CaIne and Williams initiated the proce-
dure in 1968 at Cambridge and King's College in London, and through the 
years have published on their experience. '>-10 Although early clinical results 
were disappointing. advances in surgical technique and immunosuppressive 
regimens have made the procedure an acceptable therapeutic modality for 
patients \\ith many forms of end stage liver disease. Presently, liver transplan-
tation is performed in over 20 centers in the Cnited States and Europe. 
Pathologic studies on early animal and human liver allografts were done by 
Porter11.12 in collaboration with Starz!, Initial pathologic studies are frequently 
the most difficult. since they are fraught with many confounding factors. Porter's 
meticulously detailed observations throughout the years have formed the basis 
for our understanding of the pathology.a£liveLt:,re.nsplantation. 
The current review is based on experienre-acquired in examining over 
900 surgical specimens from more than 260 adult and 200 pediatric patients 
who underwent orthotopic liver transplantation at the C niversity of Pitts-
burgh from 1981 to 1986. The spectrum of primary liver disease for which 
transplantation was performed, is shown in Table 1. 
The pathologist plays a pivotal role in the precise identification of the 
primary disease and assists in determining the causes of allograft dysfunction. 
Needle biopsies of the allografted liver have become a routine aspect of 
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TABLE 1. ORIGINAL DISEASE PRIOR TO TRANSPLANTATION 
No. (%) 
ADULT: Non-neoplastic 
Primary biliary cirrhosis 75 (29) 
Cirrhosis· (cause uncertain) 64 (25) 
Sclerosing cholangitis 38 (15) 
Hepatitis B 
Chronic active 10 (4) 
Acute fulminant- 2 «1) 
Wilson's disease ." 10 (4) 
Budd-Chiari syndrome 7 (3) 
Alpha·1-antitrypsin deficiency 6 (2) 
Secondary biliary cirrhosis 5 (2) 
Hemochromatosis 3 (1) 
Caroli's disease 4 (2) 
Toxin 2 «1) 
Other" 8 (3) 
ADULT: Neoplastic 
Hepatocellular 
Carcinoma 10 (4) 
Fibrolamellar 6 (2) 
Adenomas 2 «1) 
Cholangiolar carcinoma 4 (2) 
Epithelioid hemangioendothelioma 3 (1) 
Angiosarcoma 1 «1) 
PEDIATRIC 
Extrahepatic biliary atresia 84 (41) 
Intrahepatic biliary atresiaC 18 (9) 
Alpha-1-antitrypSln deficiency 28 (14) 
Cirrhosis "posthepatitic" 17 (8) 
Familial cholestasisd 16 (8) 
Cirrhosis (cryptogenic) 8 (4) 
Wilson's disease 7 (3) 
Tyrosinemia· 5 (2) 
Acute hepatic necrosis (drug toxicity) 4 (2) 
Congenital hepatic librosis 4 (2) 
Glycogen storage disease (type IV) 4 (2) 
Choledochal cyst with cirrhosis 2 (1) 
Hyperlipidemia 2 (1) 
Others' 5 (2) 
'Includes cases of non-A, non-B hepatitis, "autOimmune' hepatills, heterozygous alpha·'·anlitrypSln defi· 
clency. 
"Includes trauma, alcohol abuse. hyperlipidemia, cryptococcal cholangitiS. and cystic fibrOSIS. 
cSyndromatlc and sporadic. two pallents had combined Intra· and extrahepatic atresia. 
clncludes Byler's disease. 
• All patients had coexistent hepatocellular carCinomas. 
'Includes type I glycogen and neurovlsceral storage diseases. Inflammatory pseudot~morI ClrrnoSIS secon-
dary to hlS!iOcytoslS X. and methOtrexate'lnduced cirrhosIs. 
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patient care. TIll' following is intended as a )!;lIi(le to hi~topathEFlogic and 
pathophysiologic: interpretation based on obsl'r\',ltions Ill.lde in the allEl~raft 
biopsies, failed allografts. and autopsy specimens from thest' patients. 
HANDLING OF PATHOLOGIC SPECIMENS 
The varied functions of the liver combined with the di"erse etiologies of 
primary disease processes cut across disciplinary boundaries in medicine and 
biology. This is manifested by frequent requests we receive for liver tissue 
from primary resections and post-transplant specimens from these patients. 
The advent of a transplantation unit can therefore place a strain not only on 
the diagnostic facilities, but also on facilities for the handling of tissues .. \r-
rangements for freezing, cataloguing, storage. retrieval, and shipping to other 
investigators should be anticipated and plans made to share the expense. The 
rapid handling of liver tissue for research purposes when a hepatectomy oc-
curs at 2 A~fI presents its own logistic problems. 
Primary Resections 
Special handling of the original hepatectomy specimens is often required. 
Livers that require particular attention. such as those with metabolic dis-
orders, must be identified in advance to alert the pathologist and other labora-
tories to specific needs. Special procedures for handling tissue from primary 
resections as well as from post-transplant specimens are listed in Table 2. 
Recourse to previous biopsy material, surgical pathology, and operatiw 
reports is needed in order to establish the primary diagnosis. This is espe-
TABLE 2. SPECIAL PROCEDURES FOR HANDLING PRIMARY RESECTIONS, 
POST-TRANSPLANT BIOPSIES," FAILED GRAFTS, AND AUTOPSY SPECIMENS 
1. Procurement of fresh sterile tissue for microbiologic cultures. parenchymal and lymphoid 
cell cultures. biochemical or gene cloning studies. 
2. Immediate bulk freezing of tissue for biochemical or gene cloning studies. e.g .. metabolic. 
genetic. or viral diseases. 
3. Freezing of small samples in frozen sectionD compoung or special fixation for immunohis-
topathologic or electron microscopic studies, - -
4. Special gross dissectionC with/without x-ray contrast studies 
a. Porta hepatis in extrahepatic biliary atresia and intrahepatic bile duct paucity syn-
dromes and cystiC disorders of bile ducts. 
b. Hepatic vein examination in venous outflow obstruction and hepatic tumors, 
c. Gross determination of anastomotic patency and or breakdown in failed allografts ana 
autopsy specimens, 
"When tissue samples are limited, rOullne fixation ana H&E histologiC examonatlon should take precedence 
over investigational studies. 
bOCT, 
"Photographs or diagrams should document interestng cases, 
i 
i: 
I 
. , 
': 
, . 
, 
350 A.J. DEMETRIS. R. JAFFE. AND T.E. STARZL 
cially true where operative intervention has changed the underlying anatomy. 
e.g.. where Kasai-type procedures have been performed on livers 'With 
intrahepatic atresia. As a courtesy. referring institutions should be made 
aware of diagnoses established after resection in particular where there is 
disagreement with the original diagnosis or where information comes to haht 
that was not apparent before the transplantation. '" 
Needle Biopsies 
Ideally, needle bio~FD sp~~ens should be delivered fresh to the surgical 
pathology department moisHind as soon as possible after the procedure (see 
Table 2). Accompan)ing the biopsy there must be appropriate clinical informa-
tion on the surgical requisition form to answer the questions that most fre-
quently arise. This is most easily accomplished by providing an information 
sheet to be filled out by the clinical physician when the biopsy is submitted. 
The information, at a minimum, other than the general demographic data that 
are required, includes the follo\\;ng: the patient's original disease; the date of 
transplantation(s); the results of the studies of anastomotic patency. i. e., chol-
angiogram, ultrasound, arteriography; general condition of the graft at the time 
of transplantation, if less than 3 weeks post-transplant; and current immuno-
suppressive therapy, especially if additional immunosuppressives have recently 
been given. Some of this information may already be on file from the primary 
resection and prior biopsies, the most recent of which should be reviewed \\;th 
the current specimen. Directed clinical questions are important to the triage 
and handling of the tissue, e.g., ?cholangitis, ?viral disease, ?recurrent hepati-
tis. since they will direct particular attention to relevant diagnostic procedures . 
Ideally, biopsy results should be communicated directly to the attending physi-
cian as this facilitates a useful exchange of information. 
Our specimens are sectioned at 4 to 6 microns and routineh' stained \\ith 
hematoxylin and eosin (H&£), trichrome, periodic aCid-Schiff' after diastase 
digestion (PAS-D), and reticulin when indicated. The trichrome and PAS-D 
stains are of particular value in demonstrating the integrity of the bile ducts 
and ductules. Other stains that we have fbund particularly useful are those for 
iron and elastin, and immunoperoxidase techniques for identification of tht' 
hepatitis B core and surface antigens, herpes simplex \'irus, cytomegalovirus 
EC~fvFI and alpha-I-antitrypsin accumulation. 
Failed Allografts and Autopsy Specimens 
Failed allografts removed at the time of retransplantation and autopsy speci-
mens should be handled using gUidelines set up according to a defined proto-
col. Considerations for handling of the tissue specimens are similar to those 
outlined for primary resections and biopsies. However. the diagnostic ap-
prllach must be modified to answer specific qucstions pertaining to tht' re.l-
SOilS for graft failure. e.!!: .. primary or secondary failure. Very importantly. 
therefore. clost' coopt'ration hetween tht' surgeons and pathologist is needed 
in assign in!!: diagnostic' categories for livl'r allo!!:raf't fililure since pertinent 
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information such as vascular patency may not be obvious in the specimen, or 
even submitted for examination. 
The gross examination of the failed allograft at retransplant or autopsy 
should include a thorough examination of the hilar region. Particular attention 
should be given to all the biliary and vascular anastomotic sites, initially via a 
complete gross dissection of the arterial supply, portal vein, and biliary sys-
tem. This is most easily accomplished in autopsy specimens by approaching 
the anastomotic sites from the recipient's side beginning in the aorta, portal 
vein, gastrointestinal tract. or inferior vena cava, Obviously this approach is 
not possible in surgical specimens, where with a basic knowledge of the gross 
anatomy of the hilum of the liver, the vessels and bile ducts can be identified 
and dissected. 
Following the gross examination of the hilum, a horizontal cross-section 
of the superior aspect of the liver across each of the hepatic lobes reveals the 
openings of the hepatic veins. Further sectioning of the liver in a parallel 
plane is used to identify gross intrahepatic defects such as infarcts or ab-
scesses. 
Histologic sections from areas other than grossly evident defects should 
be taken according to a defined protocol in order to compare sections from 
similar locations from case to case. \Ve routinely submit several sections from 
the hilum taken in a plane perpendicular to the long axis of the major hilar· 
structures at 4 to 6 mm intervals. It is not uncommon to discover Significant 
pathologic alterations in these hilar sections especially in grafts that failed 
during the first several months post-transplant (Fig. 1). 
Frozen Sections 
Frozen section examination of post-transplant needle biopsy specimens may at 
times be useful but should be limited because of the prime importance of 
good quality histology. Nevertheless, in selected instances judicious use of the 
frozen section can be used to identify changes associated with ischemia, ne-
crosis, rejection, and, in some cases, cytomegaloviral EC~sF hepatitis. In fact, 
the eosinophilia of damaged and necrotic cells is accentuated on frozen sec-
tions and can lead to overestimation of the amount of irreversible damage . 
Bile stasis is also more conspicuous on frozen than on embedded sections. 
Our institution uses rapid processing, i.e., 5-'loO'='l1oiJTtumaround time, of 
specimens when expedient results are Dnee~Dfhere~are considerations of 
7 -day coverage to be dealt \\ith by each institutIon. 
POST·TRANSPLANT HISTOPATHOLOGY 
Donor Disease 
Prior donor disease has been seen but is not common. A donor \\ith unsus-
pected alpha-I-antitrypsin deficiency and mild fibrosis was detected for the 
first time at biopsy several ;days following transplantation. One patient re-
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Figure 1. Schematic of gross and microscopic sectioning protocol. A. A-E shows 
the location Clf protocol microscopic sections. Sections A and E include the cap-
sule. B. Representation of primary duct-to-duct anastomosis (T·tube in place), 
hilar anatomy, and further protocol microscopic sections (F-H). 
• 
cei\'ed an allograft from a donor with Fabry's disease. There was little abnor-
mality seen by light microscopy aside from i.l sma)) number of PAS-D-positin' 
foamy endothelial and pericytes of sma)) portal tract arterioles, which b~ 
electron microscopy revealed characteristic Iamcllar intracdlular storage lipid. 
In one instance there was prominent central vein and subsinusoidal fibrosis 
sug)!cstivt:' of alcohol abuse by the donor. 
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Biopsy of donor liyDE~rs before transplantation has sho\\,11 that some of tlie 
early postoperative changes are due to damage done to thL' \in>r befon' trans-
plant'ltion. Such damage may have been due to cardiac billll'e. hypotension. 
drugs. or toxins. Subcapsular hematomas, focal subcapsular necrosis. areas of 
infarction, and freeze burns from prolonged transport ha\'e been noted and 
confirmed microscopically. It is important to be aware of the focal nature of 
some of these defects especially those in a subcapsular location, since they 
may lead to sampling errors in early post-transplant biopsies. 
Harvesting Changes (Nonimmunologically Mediated Damage) 
An organ donated for transplantation can suffer injury from a variety of nox-
ious influences before or during insertion in the recipient lTable 3). Although 
all of the factors mentioned may be involved in graft injury, damage second-
ary to hypoxia before harvesting and during preservation is likely to be the 
most significant. The histologiC changes associated with harvesting injury are 
best approached by considering separately those associated with injury (de-
generative) from those of recovery (regeneration) even though O\'erlap be-
cause of the regenerative capacity of the liver is obvious. 
The changes of graft injury related to harvesting are primarily based in 
the lobule. The mildest and most common changes are microsteatosis, hepato-
canalicular cholestasis, and hepatocellular ballooning accentuated centrilobu-
larly, with spotty acidophilic degeneration of hepatocytes throughout the lob-
ule. Kupffer cell hypertrophy, mild centrilobular or portal tract interstitial 
hemorrhage may also be seen early. Centrilobular hepatocellular coagulati\'e 
necrosis without collapse of the reticulin architecture may be seen as the 
degree of injury increases. Centrilobular dropout of hepatocytes with reticulin 
collapse appears quite severe because of the associated hemorrhage into the 
area. Severe ischemia may lead to a peculiar periportal hepatocellular necro-
sis, and be associated with subcapsular necrosis and focal infarcts. 13 The de-
gree of injury is gauged by the area of the lobule that is affected as well as the 
severity of hepatocellular damage. Polymorphonuclear inflammation of the 
central vein may be a feature of harvesting damage. Examples of differing 
degrees of harvesting injury are shown in Figure 2. 
The mucosal health otthe donor galtbi~ssessed in the pediatric 
population in an attempt to prognosticiife-ril::K~~alK Although the epithe-
lium showed changes of marked darmi:ge aiRfl"'Eiif*lir....mh inflammation in some 
TABLE 3. HARVESTING INJURY: NONIMMUNOLOGIC DAMAGE OF THE ALLOGRAFT 
PRIOR TO REVASCULARlZATION IN THE HOST 
Insults while in the donor. Ischemia, shock, cardiac failure, drugs, toxins, a.lcohol, traumatic 
graft injury, and donor disease 
Insults during harvesting and transport. Prolonged cold ischemia and freeze burns 
Insults during implantation. Bench time (vascular trimming), hypotension, warm perfusion, 
and anesthetic agents 
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Figure 2. Harvesting injury. Needle biopsies (first 2 weeks post-transplant) 
demonstrating: B. Centrilobular ballooning of hepatocytes associated with he-
patocanalicular cholestasis. b. Steatosis with random acidophilic degeneration of 
hepatocytes (arrows). c. Periportal hepatocellular necrosis (PT = portal tract. 
necrotic area is outlined by arrows). d. Edge of infarct (inf). 
patients, this did not correspond to ischemic damage present ,,;thin the 
graft. 91 , 
Regenerative activity becomes evident within t1~e first 2 to 3 days post-
transplantation. The microscopic findings in general reflect the degree of 
injury. \lild lobular disarray with pseudorosetting of hepatoc~·tesI nuclear 
el1lar~ement with prominent nucleoli, and hepatocellular mitosis are indica-
tive of mild regenerati\'e changes. Phagocytosis of cellular debris ,,;th KupfTer 
cell hypertrophy is also observed. 
Prominent ductular proliferation at the edge of the limiting plate sur-
rounded by a mild predominal)tly polymorphonuclear inflammatory infiltrate 
(cholangiolitis, Fig. 3) may Ill' the result of Sl'vere injury with extensive necl'o-
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Figure 3. Cholangiolitis assocIated with repair of harvesting injury. Note the 
cholangiolar proliferation at the edge of the limiting plate surrounded by neutro-
phils (inset). This histologic picture can be easily confused with the early changes 
of duct obstruction and/or ascending cholangitis (see text). 
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sis. This may be accompanied by areas of infarction, abscess formation, bile 
leaks, and graft failure. Cholangiolar cholestasis may also develop in severe 
ischemic injury simulating large duct obstruction IUS or cholangitis compli-
cated by sepsis, which was frequent in early animal models16 and in humans. 4,8 
A useful histologic criterion for distinguishing ischemic injury from duct ob-
struction and cholangitis is the presence of significant hepatocellular injury, 
i. e., centrilobular coagulative necrosis, seen in harvesting injury, whereas 
cholangitis, rather than cholangiolitis, is seen in duct obstruction. Useful 
indicators of the degree of harvesting injury as well as of the presence of duct 
obstruction, other than the histopathology, Tnclude"':..the-surgeon's opinion of 
the viability of the graft at the time of iinp1ant1ili~"i;f~i~ng or falling trend 
as well as the level of cytosolic hepatoeelhjlar-eftwy~mmediately and 
shortly after transplantation,13 the presence of T-tube bile drainage, the re-
sults of sonographic and cholangiographic studies of the graft, and, obviously, 
the timing of the biopsy. However, these two processes-ischemia and chol-
angitis with sepsis-may be intimately related.71718 
Findings in follow-up biopsies done on patients whose initial specimen 
demonstrated harvesting injury depend on the balance between the injury 
and regenerative capacity of the graft. Biopsy of livers manifesting changes of 
mild injury show quick resolution with minimal residua. Those with a more 
severe insult may show a gradual normalization of the biopsy findings usually 
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over a period of 2 to 3 weeks if the initial damage permits orderly restructur-
ing.of the hepatic architecture. This implies only mild intralobular collapse of 
the reticulin architecture and modest cholangiolar proliferation. The hepato-
cellular ballooning may, however, persist for several weeks and the hepato-
canalicular cholestasis for 1 to 2 months. If the centrilobular reticulin pattern 
is intact, but only collapsed due to hepatocyte dropout, then regeneration is 
rapid and complete. If, however, the initial damage is accompanied by more 
severe interlobular architectural collapse and cholangiolar proliferation, graft 
failure or residual damage _such as pericentral and portal fibrosis may develop 
as a consequence. 
Although the histolggic damage may appear quite severe, it is important 
to stress that histology can overestimate the damage and underestimate the 
potential for repair, especially when clinical and biochemical indicators of 
liver function are improving. One must also realize the subcapsular sampling 
problem can further confound the picture. 13 
The pathophysiologic mechanisms which lead to the morphologic mani-
festations of graft injury related to harvesting are yet to be precisely defined. 
The pathologic changes are similar to those described in other studies of liver 
allografts (as well as in non grafted livers), injured by a variety of mecha-
nisms. 15. 19-1J Several clinicopathologic studies of liver damage due to the toxic 
shock syndrome and heat stroke21 •22 which manifest similar pathologic altera-
tions have, in addition to ischemic injury, suggested a role for bacterial endo-
toxin. Brettschneider et al 17 documented colonization of the hepatic paren-
chyma, portal vein and peripheral blood, and bile with organisms from the 
intestinal tract in ischemical1~D damaged animal liver allografts. These findings 
offer a reasonable explanation for the presence of both cholangiolitis and 
cholangitis associated \\ith ischemic injury. Starzl pOints out the need to 
protect the ischemically injured graft from bacterial seeding by the use of 
appropriate antibiotic therapy and from rejection using immunosuppressive 
therapy. 7. 17.15 
Although many factors may be invoh'ed in harvesting damage, it is appar-
ent that the injury related to ischemia, bacterial seeding, and the oper'lti\"e 
procedure play key roles. This is further supported by the observation of 
similar findings in allografts which have undergone arterial thrombosis or 
severe hypotension after initi~l satisfactory function. Although the pathologic 
changes of ischemic damage may not be absolutely diagnostic, their separation 
from those of coexistent rejection can be recognized. The most important 
distingUishing feature is the predominantly mononuclear nature of the infil-
trate seen ,,;th early or acute cellular rejection (see section on Rejection). 
Therefore. the biopsy in the early postoperative phase can be of great value in 
distinguishing between rejection and harvesting changes and may be useful in 
gUiding further diagnostic studies or theraputic intervention (Fig. 4). 
Whether coexistent toxic insults from pharmaceuticals play an additional 
role is uncertain since in the early postop("rati\'e period these patients ha\'e 
been exposed to anesthetic agcnts24 alld are receiving intravenous ste-
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Figure 4. Harvesting injury with early cellular rejection. There is residual lobular 
steatosis and balloonrng with mild ductular proliferation as features of harvesting 
injury. Note however. the mononuclear predominance in the portal infiltrate along 
with early subendothelial and bile ductular infiltration (arrows). 
rOids,24-26 cyclosporine. r. and antibiotics.24 However, similar changes are not 
consistently observed in biopsies from patients treated with supplemental 
intravenous steroids for a rejection event temporally remote from the opera-
tive procedure and not complicated by ischemia. Therefore, although one 
cannot entirely disregard toxic influences, it seems clear that factors related to 
prolonged ischemia and the operative procedure are major etiologic factors in 
harvesting injury. 
Rejection 
Rejection of an a1lografted organ has been broadly defined as an "immuno-
logic" reaction against the graft with the potential to lead to graft damage and 
eventual failure. Defining the histo1dgi~K<;:~~gstic~ of such a reaction in 
the liver has been a particularly difficult -tasiE'if(l.c-e :many disease processes 
affecting the liver can be broadly define-l as "immunologic" and a -~yriad of 
technical complications may be seen. 5.7- 9 Therefore, up to the present, many 
of the pathologic lesions attributed to rejection have been reinforced by clini-
cal observations in the recipient so that the diagnosis of rejection has been 
based on the exclusion of alternative reasons for graft dysfunction combined 
with a consistent hepatic histopathology. 
The primary antigenic targets of rejection reactions in any organ are the 
major histocompatibility complex E~eCF antigens, which are cell surface gly-
coproteins expressed on the cytoplasmic membranes of certain cellular sub-
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sets within an organ. 28 Other tissue-specific antigen systems such as those 
encountered on endothelial cells29,:lO and bile ductules may also playa role. 
The ~leC antigens are broadly divided into classes I and II, which are 
thought to be important in cytotoxic T-cell reactions and proliferative mixed 
lymphocyte reactions, respectively, 2& Both classes may serve as targets for 
cytotoxic cells. 31 ,32 It is known that class I antigens are expressed to at least 
some degree on all nucleated cells,28 although the density of antigen expres-
sion may vary considerably, as is seen in the liver, 33 Normally (nonallografted, 
nondiseased livers), c1asKs:;Kt~~~e __ strongly expressed in endothelial, 
reticuloendothelial, and 1nle:K~lir elilih.elial cells and only ver\" weaklv on 
hepatocytes. Class II antig~eexpressed strongly on sinusoid'al cells: en-
dothelial cells of small capillary-sized vessels, and dendritic cells which may 
be closely associated with bile ductules in the portal tracts. Following trans-
plantation, class I antigens are induced on hepatocytes and enhanced on bile 
ductules, and class II antigens become detectable on the larger vessel endo-
thelial cells and in biliary epithelium. 34.35 This induced ~feC expression may 
result in enchanced immunogenic potential since antigen density on targeted 
cells is thought to playa role in recognition. 31.32 
Effector mechanisms mediating allograft rejection encompass a variety of 
immunologic pathways mediated by mononuclear cells, immunoglobulins, 
complement, coagulation proteins, and platelets. 32.36 Although antibody and 
complement deposition (humoral rejection) have been seen in anim~1 and 
human liver allografts during rejection, their role in mediating graft destruc-
tion is thought to be less important than in the kidney.37 Porte; emphasized 
their appearance after, rather than before, damage mediated bv cellular 
rejection. 12.36 Undoubtedly as more experience becomes a\'ailable. the role of 
humoral factors in hepatic rejection will be more precisely defined. The fol-
lo\\ing discussion of the morphologic findings win be limited to cellular rejec-
tIon that occurs under the influence of cyclosporine and steroid maintenance 
immunosuppressive therapy. 
Hyperacute Rejection. The diagnosis of "hyperacute rejection" of an hepatic 
allograft has not been made in this series of patients despite the presence of 
transplantation across major blood group incompatibilities or positive Iympho-
c~·totoxic cross-matches. Some ischemically damaged livers ma\' show marked 
deposition of immunoglobulins. 13 Several patients haw been 'identified \\'ho 
haw undergone an accelerated deterioration of graft function « 1 week) 
which appears to ha\'e been immunologically mediated. HO\\"e\·er. staining for 
immunoglobulin and complement deposition was either nt'!!;ati\e or difficult 
to interpret. Clearly more inwstigatiolla! work is net,ded in 'this .Lrea. 
Acute Rejection. The earliest changes ohserved during a rejection reactioll 
within the liver ha\'l' lwen l'xtt.'llsin'h· dO('ullll'nted h\· Porter alld oth-
ers. 11.I1.1'1-44 \!ollonudl';tr ('el\s aCt'1l1l111);;tl' in the interstitiulll of til{' portal 
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vessels. small veins. and near cUIlIIt,ctin.' tissue..' dendritic cells. The endothe-
lial cells may be lifted away from the underlying connective tiSSUt'. This 
usually occurs between i and 10 days and 2 to 3 months post-transplant in thl' 
immunusuppressed host but has been obscryed as early as 3 to -1 da\·s. The 
early lesion may be very focal. making the early dia~nosis of rejection suscep-
tible to sampling error. The infiltrate consists of an admixture of large (blas-
toiel) and small lymphocytes, some of which have plasmacytoid cytologic fea-
tures, monocytoid cells, and lesser numbers of neutrophils and eosinophib 
which accumulate in the portal tracts and lead to portal expansion. Immuno-
logic staining for phenotypic characteristics has shown that the majority of 
infiltrative cells express T-cell antigens as would be expected. although 8-
cells, macrophages, neutrophils. and eosinophils are also present. 3-1 The num-
ber of eosinophils varies but can be quite striking, and may simulate .m 
allergic drug reaction. 24 The portal inflammatory cells are seen within the 
basement membrane and occasionally within the lumen of bile ductules. Duc-
tular cell hyperplasia with enlargement of the cells and an increase in the 
nuclear to cytoplasmic ratio is the most frequent finding in specimens with 
rejection obtained within 2 months of transplantation; however, frank biliary 
epithelial cell damage is also coexistent. The degenerative changes seen in the 
biliary epithelium are subnuclear vacuolization, nuclear pyknosis or karyor-
rhexis, eosinophilic degeneration or frank luminal disruption. A proliferative 
response with neocholangiolar formation at the edge of the limiting plate is 
not a prominent feature, even in the face of extensive ductular damage. 
Although in early episodes of rejection the limiting plate is generally intact, 
"spillover" of the mononuclear cells into the periphery of the lobule 'With 
periportal hepatocyte necrosis can also be seen. Scattered mononuclear cells 
similar in appearance to those seen in the portal tracts can also be seen within 
the sinusoids or traversing the space of Disse. ~fononuclear cells may also be 
seen beneath and around the endothelium of central veins and may be asso-
ciated with centrilobular hepatocyte necrosis. Concomitant ischemia before or 
associated with rejection7.38 may also contribute to the hepatocellular injury in 
the periportal and centrilobular areas or. alternatively, the periportal and 
pericentral hepatocytes are uniquely susceptible to a variety of insults. 
~edium-to-farge vessel damage is occasionally present but is found pre-
dominantly in the hilar vessels -whiCnar~eenIt in biopsy specimens. 
Inflammatory vasculitis of vefn~_ or-=-arle®~ without associated fibri-
noid necrosis and thrombosis, can occrg:I::aul~orritormly present. Arterio-
lar inflammation and necrosis are uncommonly detected' in biopsy specimens. 
Inflammatory cell infiltration around and into peripheral nerves trunks in the 
hilum may be related to the expression of ~l He antigens by these structures. 
The histologic grading of acute cellular rejection is based on a subjective 
impression of the degree of exuberance of the portal inflammation combined 
with the presence or absence of centrilobular hepatocellular necrosis present 
in the biopsy (Figs. 5 and 6). It is difficult, however, to predict the degree of 
elevation of serum liver enzyme levels based on the histologic grading. It also 
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Figure 6. Additional features of acute cellular rejection. a. Acute arteritis, a rare 
finding in biopsy specimens, and although more frequent in failed grafts this 
feature is not common. b. Infiltration of hilar nerve trunk. 
appears that in most instances, regardless of histologic grading. acute cellular 
rejection is reversible with bolstered immunosuppressive therapy. This is 
particularly true with the advent of monoclonal antibody therapy used to treat 
acute cellular rejection. ~ A retrospective review of hepatectomies for refrac-
tory rejection did not show that "severe" cellular rejection was a necessary 
antecedent (see section on Chronic Rejection). 
Rebiopsy after a period of 1 to 2 weeks follo\\;ng successful treatment of 
rejection shows a diminution of the inflammation. particularly the mononu-
clear cell fraction with residual neutrophils. plasma cells. and eosinophils; 
mild portal edema; mild ductular proliferation with or without ductal cholesta-
sis; and at times a mild increase in portal connective tissue. The endothelial. 
biliary epithelial, and portal tract connective tissue cell nuclei may remain 
prominent. The findings in biopsy specimens obtairled during or after treat-
ment of suspected rejection may easily be confust:~¢1he earlymanifesta-
tions of biliary tract obstruction or acute chol~nCflUdtti@~e of the paucity of 
lymphoid cells while other changes persist. eoyy:e~~e~;- th'€presence of hy:per-
trophic endothelial and epithelial cell nuclei and a portal tract infiltrate 
weighted toward plasma cells and eosinophils with a lesser number of neutro-
phils are suggestive of prior treatment of rejection. Therefore awareness that 
recent antirejection therapy has been administered before obtaining the bi-
opsy is critical to interpretation and cannot be overemphasized. A diagnosis of 
"partially treated rejection" is rendered on those biopsies in which a previous 
diagnosis of rejection is followed, on a subsequent biopsy. by a picture of 
diminished cellularity but still having the endothelial and epithelial changes 
(Fig. 7). We are not able to make prognostic inferences about further poten-
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Figure 7. Treatment of acute cellular rejection. a. Mild-to-moderate acute cellular 
rejection (10 days post·transplant). b. Rebiopsy after 15 days of treatment with 
OKT3 monoclonal antibody (Ortho Pharmaceuticals, Raritan, NJ). Note the di-
minished portal cellularity, with residual endothelial and epithelial changes. 
tial responses to antirejection therapy based on the response seen in the 
biopsy. 
We have seen three cases where there has been ocjecthe improwment 
in the histologic features of an acute rejection episode without any alteration 
of the immunosuppressive therapy. Also, incidental biopsies taken during 
abdominal surgery have shown prominent rejection changes \\;th a relative 
paucity of clinical or biochemical manifestations of h"er injury. Long-term 
follow-up of these confounding instances is lacking and their meaning is not 
clear. Identical obsen'ations have been made in experimental animals and in 
several human liver allograft series. PI~1~SK4T 
Chronic Rejection. Although the separation of allograft rejection into acute 
and chronic forms may be somewhat artificial and established by convention, 
there are some differences in the histologic appearance of rejection episodes. 
These different forms I)f rejection cannot be separated solely on a chronologic 
basis. However, in general. those episodes occurring within the first 2 postop-
erative months generally appear as described above (see section on .\cute 
Cellular Rejl'ction) and those occurring at later time periEFdsP~-~lKn clS de-
scribed below for "chronic rejection." \laJlY of the antigenic targets in the 
graft are the same since the bile ducts, l'ndothelial t'l'lls. and hepato('ytes 
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pllblished observation). The 'donor Kllppfer cells however. are replaced by 
those of the recipielltl1·~~ (unpublished obsen·ation). 
The morphologic features in "chronic rejt·etion" can best be described by 
comparing and contrasting the appearance of this type of rejection with those of 
acute rejection. The characteristic lesion consists of the follOWing triad of mor-
phologic findings: (1) a mild-to-moderate mononuclear portal tract infiltrate. (2) 
damage and loss of small bile ductules. and (31 arteriolar thickening or hyalin-
ization or large vessel changes as described below. Subendothelial inflamma-
tion of portal \'enules is less striking. Adherence to the presence of the com-
plete triad of findings is helpful since lack of even one may diminish the 
diagnostic sensitivity of the biopsy. Note, however, that the diagnosis of 
chronic rejection can be made in the absence of a Significant lymphoid infil-
trate. particularly when the other changes, i.e., duct loss and vascular lesions. 
are present. Features of chronic rejection are shown in Figures 8 and 9. The 
composition of the infiltrate differs somewhat from that found in earlier epi-
sodes of rejection in that there are fewer large or "blastoid" lymphocytes, 
neutrophils, and eosinophils with some subjective increase in plasma cells. In 
fact, if a significant number of "blastoid" lymphocytes are present in a biopsy 
obtained later than 2 months .post-transplant, one must consider the possibility 
of discontinuation of immunosuppressive therapy, Epstein-Barr virus (EBV) or 
C~tyI infection, or a lymphoproliferative disorder (Fig. 10).49 Over a period of 
time which varies from patient to patient, the portal tracts may become devoid 
Figure 8. ChroniC rejection. Failed graft (4 months post·transplant) demonstrat-
ing portal tract (PT) lacking bile ductules. secondary centrilobular hepatocanalicu-
lar cholestasis. mild hepatocellular ballooning, and lack of "true cirrhosis.' 
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Figure 9. Chronic rejection. a. Needle biopsy (10 months post-transplant). b, C. 
Failed allograft (13 years post-transplant). Note the mild portal inflammation in a 
and b. the residual biliary epithelial cells in b and marked luminal narrowing of a 
portal vein by subintimal foam cells in c. Identical chronic vascular lesions can be 
seen in arteries. most often in hilar sections of failed grafts. 
of small ductules and slightly expanded by fibrosis. :\ true portal-to-portal 
cirrhosis ,.,;th inflammatory cell acti"ity at the edge of the limiting plate is 
rarely seen in end stage rejection. The limiting plate may have a "moth-eaten" 
appearance due to the lining up of inflammatory cells near the ed~e of the 
lohule. Howe"er, extension of the inflammatory cells deep into the lobule with 
l'x!t'nsive pieceme.d necrosis is not a prol11illt'nt feature. Lobular alterations 
include mild regenerative changes, slight anisocytosis and anisonudeosis. 
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Figure 10. Post-transplant Iymphoproliferative disorder involving the liver. Failed 
graft (13 years post-transplant), note the massive portal expansion by a relatively 
monomorphic population of large Iymphoplasmacytoid cells. The infiltrate over-
runs the portal landmarks. 
Kupffer cell prominence, focal mild acidophilic hepatocyte dengeneration, a 
progressive secondary centrilobular hepatocanalicular cholestasis, atrophy of 
the centrilobular hepatocytes resulting in an apparent widening of the sinu-
soids, and randomly distributed small clusters of sinusoidal foam cells. A fine 
perisinusoidal and central vein fibrosis is also frequently present. 
A useful guide for the determination of loss of bile ductules associated 
with late cholestasis can be derived from ~akanuma and Ohta'sSO histometric 
study of normal livers compared to those with primary biliar\' cirrhosis. ~or­
mally, ductules and arterioles run in parallel in the portal tract. Arteries with 
a lumen less than 95 microns are accompanied bv ductules of a similar size 
within a radius of three times the arterialdi~eter -70 to 80 percent of the 
time. Utilizing these figuresiora normal ~ulrCntrolpopulation one can get 
some idea as to the presence or absence of ductula~l;ssK 
The findings described above may be quite subtle and require close 
histologic examination but nonetheless predict a progressive graft deteriora-
tion refractory to bolstered immunosuppression and eventual graft failure. 
Surprisingly, in allografts removed after longstanding chronic rejection. the 
inflammatory infiltrate may be inconspicuous. However, one also observes a 
paucity of ductules. Perhaps one of the prime antigenic targets has been 
removed, 
Vascular changes found in the hepatectomy specimen of grafts after long-
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standing and indolent rejection include arteriolar thickening. fibrointimal hy-
perplasia, and deposition of subintimal foam cells in hilar arterial and venous 
channels. The arterial changes may be severe resulting in marked luminal 
narrowing with vascular compromise to structures supplied by the arterial 
tree. Deterioration of the septal bile duct walls \\;th sloughing of the epithe-
lium has been seen in association \\;th these chronic vascular lesions. The 
vascular lesions may therefore contribute to loss of biliary epithelium and, 
possibly, biliary stricture formation. 
In contrast to th*K?FgItl:~putlil!ed for acute cellular rejection, the pre-
sence of histologic find.i.x},g$i.eonsistent with chronic rejection usually correlates 
well \\ith the presen~e gEa~inbKstructive serum liver enzyme pattern. Also, 
chronic rejection is less responsive to bolstered immunosuppressive therapy, 
suggesting that some of the immunologic damage is irreversible. 
Considerable overlap exists in the morphologic patterns of rejection out-
lined above, particularly partially treated and chronic rejection. and therefore 
when revie\\ing biopsy specimens one may not be able to precisely categorize 
each one. However, an estimate of the degree of potentially irreversible 
damage (i.e., loss of ductules, arterial sclerosis, fibrosis] and potentially rever-
sible (i. e., actively destructive cellular infiltrate) is useful information for gUid-
ing immunosuppressive therapy. Adding to the complexity of the situation is 
the fact that cases categorized as "chronic rejection" may be seen in the first 
several months post-transplant and those diagnosed as "acute rejection" much 
later. 
Donor-Derived Hilar Lymph Nodes 
Hilar tissues in failed allografts often contain enlarged lymph nodes, particu-
larly in grafts that failed dUring the first month. The nodes can be identified as 
being of donor origin by virtue of their location and by immunologic staining 
using type-specific anti-~[eC antibodies. Anatomicalk the afferent vascula-
ture and lymphatics should remain intact after the pro~edure and therefore be 
a site of host sensitization to donor immune cells. 51 
:\'odes from grafts in residence for a few days show hypertrophy of the 
sinusoidal lining cells and endothelial cells of the paracortical high endothelial 
venules (HE\,). There is dilatation of the peripheral and nodal sinuses. \\'hich 
contain edema flUid. large lymphoid cells. pigmented macrophages. some 
\\ith phagocytized debris. and neutrophils. Thereafter. during the first week 
large or blastic lymphocytes are observed. particularly beneat'h and surround~ 
ing paracortical HEYs and within the sinllsoids. 'Lymphuid proliferation 
ensues leading to marked expansion of the paracortex ll\ a \'ariet\' of immuno-
bbsts, some with plasmacytoid features. smaller l\lnp·hoc\,tes. 'and monoc\,-
tOld cdls. ~fitotic acti\'ity and iml11unoblastic transformation I1lay be quite 
PflJll1ilH,'nt in this area. The endothelial and sinllSoi(bl linin!! cclls 111a\' be-
COlllt' undermined by the IYlllphoid cclls and lifted frum the ;lgfdcrlyDin~ con-
lll'div(' tissul', similar to the findings descrihed in lin'r rl'j{'ction. Gl';minal 
ccnter formation is either inconspicllolls or ahsent. Tht'Sl' fiDlldin~s are similar 
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to those described by Porter. 11.12 except for the unifimn presence of markedly 
enlar~Kwd and active germinal centers which we have not obsl'l'\,ed. It is proba-
ble that the type of immunosuppressive agent is responsible for this difference 
since our patients receive cyclosporine and Porter described patients recei\'-
ing azathioprine. Nodal tissue in residence for longer periods of time tends to 
be much smaller and sometimes shows a relative paucity of lymphocytes and 
an increase in connective tissue and in the number of sinusoidal reticuloendo-
thelial cells. 
Other pathologic changes involving the nodes have included infarction. 
marked sinusoidal dilatation. and C~fsI bacteriaL or fungal infections. 
Immunoperoxidase staining of the nodes using type-specific anti-~ HC 
antibodies for which there was a donor-recipient mismatch have shown a 
gradual transition of the lymphocyte population within the nodes from that of 
donor to that of recipient. 51 Nodal tissue removed from two patients 1 and 2 
years post-transplant has shown the basic reticular architecture and vascula-
ture of the node to be of donor origin whereas a majority of the resident 
lymphocytes were of recipient origin. Interestingly, the basic T- and B-cell 
segregation of the lymphocytes was similar to that seen in normal nodes. 
Functional Studies 
Concepts concerning the histopathologic findings associated with hepatic re-
jection are supported by in vitro functional analysis ofT-lymphocytes obtained 
from needle biopsy and failed allograft specimens. Lymphocytes extracted 
from specimens showing the histologic features of ischemic injury either failed 
to expand in culture or demonstrate donor-specific proliferative or cytotoxic 
activity. However, those diagnosed as rejection uniformly expressed donor-
specific reactivity directed at class I and class II ~feC antigens which are 
preferentially expressed on structures targeted by the rejection reaction. 52 
Viral Hepatitis 
The morphologic manifestations of viral hepatitidies in liver allograft biopsies 
are not unlike those described in immunosuppressed patients without liver 
allografts. The following descriptions of viral hepatitis occurring in allografts 
are presented in their order of frequency, --_.'-_"'''''-<.-li'-
KD-K;;:--~ 
Cytomegalovirus. CMV is the most frequent1~nop~_ viral hepatitis in this 
population of liver allograft patients and liver biopsy is the definitive means of 
diagnosis. 53 Clinically, patients with C~fs hepatitis present with prolonged 
pyrexia and cannot be distingUished from patients \\ith rejection. This infec-
tion occurs most frequently 4 to 5 weeks after initiation of the immunosup-
pressive regimen (range 15 to 113 days). It is quite unusual to see C~1s 
earlier than 3 weeks post-transplant, unless the patient has been previously 
immunosuppressed. Early reinfection, before 7 days, has been seen after 
retransplantation where the resected allograft was infected. 
The diagnosis of CMV hepatitis rests upon the identification of nuclear or 
l 
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cytoplasmic inclusion bodies, but awareness of the characteristic response to 
CMV will prompt a search for the virus when inclusions are sparse. 
The characteristic histopathologic pattern which should initiate a search 
for CMV inclusions is the presence of small "microabscesses or microgranulo-
mas" scattered at random throughout the lobule. These are composed usually 
of small collections of neutrophils (10 to 20 cells) or a mixed collection of 
inflammatory cells surrounding a necrotic hepatocyte, in which, or in nearby 
levels, inclusions are found. A somewhat similar pattern of neutrophil aggre-
gates can be seen in ba:eterial"'Sepsis- or subsequent to intra-abdominal sur-
gery, but obviously without~~D-CMV inclusions. In a given section, the 
number of cells with intracytoPlasmic'virus exceeds the number of cells \vith 
nuclear inclusions, so that it is important to recognize cytoplasmic virus when 
it is present. Immunostaining for viral antigens, in general, shows more than 
can be recognized on H&E sections. C~fyI debris may be recognized in 
neutrophilic clusters even when inclusions or other evidence of a cytopathic 
effect are lacking. 
Damaged tissue ""ith active rapidly dividing cells such as the reactive or 
granulation tissue near infarcts, abscesses, and suture lines is also fertile soil 
for CMV growth. Therefore, when such tissue is encountered a more careful 
search is warranted. 
Subsequent biopsies from patients who initially manifest C~fs hepatitis 
and in whom the infestation by C~fs increased, showed that there was little 
inflammatory cellular reaction to the infected cells. Conversely, in situations 
where the CMV infestation was less severe in a repeat biopsy, the neutro-
philic response to the virus was obvious. The implication is that when the 
\irus is being contained, the neutrophil clusters remove the damaged cells. 
CMV and rejection can be diagnosed separately and independently on 
the same biopsy. The presence of C~fs is recognized by the characteristic 
cytomegalic changes with inclusion bodies and in some instances may be 
located in portal tract structures. Nonetheless, C~fs does not cause portal 
tract changes mimicking rejection. Rejection on the other hand is recognized 
by the characteristic portal findings. Although a precise definition of the role 
each plays in graft damage may not be possible, we generally communicate 
the "severity" of C~Es infection based on the number of inclusion bodies 
found and the severity of the rejection based on the degree of destructive 
portal inflammation (Fig. 11). 
Treatment of patients whose biopsies manifest changes of both C~fyD and 
rejection has been individualized depending on which lesion appeared the 
most severe. Immunosuppression was curtailed when C~Es infestation was 
high and increased when the infestation was low. 53 
Hepatitis B. All liver allograft patients to date with chronic active hepatitis B 
(HBsAg positive serologically) before transplantation surviving more than 3 
months (eight total) have had recurrence of the B viral infection in the graft. 
These recurrences occurr~d over a p~riod of time similar to that seen in 
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Figure 11. CMV hepatitis with and without rejection. a. Needle biopsy (4 weeks 
post-transplant) showing the characteristic "microabscess" response to CMV· 
infected hepatocytes. b. Needle biopsy (5 weeks post-transplant) showing the 
portal tract changes of acute cellular rejection with infiltration and damage of the 
biliary epithelium (arrowhead) along with a CMV-infected hepatocyte at the edge 
of the lobule (arrow). 
primary acquisition of the disease (longer than 8 weeks). The one exception 
was a patient transplanted dUring acute fulminant hepatitis B with massive 
hepatic necrosis who developed serologic evidence of viral immunity (positive 
anti-HBs and anti-HBc) postoperatively. A detailed description of these cases 
with the histopathologic findings has been published elsewhere.'"' The 
patients most commonly presented with nausea, malaise, jaundice, and an 
increase of hepatocellular enzymes (ALT and AST) coincident with the reap-
pearance of HBeAg in the serum and HBcAg in tissue. The diagnoses were 
confirmed by needle biopsies. , . 
The histopathologic manifestatio~~~ljefig€tion of the allograft liver 
may lead to a variety of alteratio~s~-q11Dre~~atterns of allograft pathology 
have been seen in association with recuDrre:nRit:B~prominent lobular disar-
ray, ballooning, inflammation, and necrosis; (2) mild lobular disarray \\oith 
minimal inflammation and conspicuous acidophilic necrosis of hepatocytes; 
and (3) moderate lobular disarray with portal inflammation, active piecemeal 
necrosis, and little to no bile ductular or portal venous damage. Common to 
all the patterns was the evidence of a preferential lobular insult with minimal 
to no damage to structures targeted by rejection (bile ducts and venous endo-
thelium) (Fig. 12). Therefore, the appearance is not dissimilar to HB seen in 
immunosuppressed patients who have not had liver allografts. Immunoperoxi-
dase staining (particularly HBcAg) and serologic studies are absolutely essen-
,t 
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Figure 12. Recurrent hepatitis B in the liver allograft patient. B. Needle biopsy (7 
months post-transplant) showing typical acute viral hepatitis with prominent loou· 
lar inflammation and spotty hepatocyte necrosis, b. Needle biopsy (6 months 
post-transplant) showing individual acidophilic necrosis of hepatoCytes (small ar-
rows) with little portal or lobular inflammation, c. Needle biopsy (10 months 
post-transplant) showing marked lobular disarray, ballooning of hepatocytes, and 
inflammatory cell infiltration at the periphery of the lobule surrounding ballooned 
hepatocytes (inset). Common to all the specimens is a preferential lobular or 
hepatocellular insult with little damage to bile ductule!; (large arrows). 
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tial for establishing the correct diagnosis. Follow-up biopsy in patients who 
had clinically .lIld hiochemically recon'red li-olll an acute episode of graft 
dysfunction secondary to HB in two instances showed little or no graft pathol· 
ogy although the patients continued to express Iart;e amounts of viral antigens 
in the serum ,md tissue. Therefore. some of the histologic changes may be 
quite subtle and may represent infection without prominent inflammatory cell 
destruction of hepatocytes secondary to immunosuppressive therapy_ 55 :'lie,·· 
ertheless, when H B is a cause of graft dysfunction a preferential lobular insult 
is seen. 
Treatment of recurrent hepatitis B with increased immunosuppression 
has resulted in death secondary to sepsis in two cases_ In these two cases. the 
autopsy specimens showed less infiam.mation than the previous biopsies- De-
creased suppression has resulted in acute self-limited graft dysfunction with-
out viral clearing or fulminant hepatitis requiring retransplantation (one case 
each). Where there has been no change in therapy, the result has been a 
self·limited acute disease without viral clearing (one easel or maintenance of a 
low-grade chronic disease in three instances. 
Herpes Simplex Hepatitis. Herpes simplex hepatitis is most frequently seen 
more than 2 weeks post-transplant and is related temporally to augmented 
antirejection therapy. The pathologic lesions in biopsy specimens are quite 
characteristic and similar to those seen in nonimmunosuppressed patients. 
There are well-demarcated areas of coagulative necrosis of variable size \v1th-
out respect for the lobular architecture. Neutrophils, nuclear debris, hepato-
cytes with characteristic ground glass intranuclear inclusions (Cowdry type Al, 
and occasional multinucleated giant cells can be seen within and at the per-
iphery of these necrotic zones. Although these findings may be confused 'v1th 
adenoviral hepatitis, immunoperoxidase staining for herpes simplex viral anti-
gens is confirmatory (Fig. 13). 
Adenoviral Hepatitis. Adenovirus has been identified as the cause of viral 
hepatitis in three pediatric patients. The hepatic lesions seen were similar to 
those described for herpes simplex except for a lesser degree of hepatocellular 
necrosis and a more granulomatous response. Adenovirus was confirmed by 
culture and viral particles demonstrated by ele~on iilicroscop-y. C~[s inclu-
sions were present Simultaneously-in oneKK"KpfK~fg1~kK1~IsesK One was noted on 
biopsy and in an allograft resection~out did not-n~elDgcDin the sub.sequent liver 
transplant. The others were noted on biopsy, and both of these patients 
survived (Fig. 14). 
Non-A, Non-S Viral Hepatitis. The diagnosis of non-A, non-B hepatitis is quite 
difficult if not impossible to substantiate at this time in a liver allograft biopsy, 
because, as is the case in non allografts, the diagnosis is one of exclusion. 56.57 
Nevertheless, we have seen biopsy specimens with a predominantly lobular 
alteration with no serolOgiC or morphologic evidence of currently identified 
I· 
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Figure 13. Herpes simplex viral hepatitis. Needle biopsy (5 weeks post-trans-
plant) showing well-demarcated area of coagulative hepatocellular necrosis. 
which contains neutrophils and cellular debris. 
viral liver pathogens or evidence of adverse drug reactions. Several of these 
patients had chronic active hepatitis \\-;th cirrhosis of undetermined etiology 
as their original disease. The biopsy specimens have shown active piecemeal 
necrosis without damage of vessels or bile ducts and mild lobular disarray. 
Prominent spotty acidophilic degeneration of hepatocytes with only a mild 
inflammatory infiltrate similar to that described with HB has also been seen. 
Although undoubtedly the allografted patient is susceptible to this type of 
viral hepatitis. further identification of the pathogen(s) must be made to sub-
stantiate such a diagnosis in this group of patients. Nevertheless. combining 
experience gained from the study of viral HB \\;th published studies on 
non-A. non-B hepatitis in nonimmunosuppressed hosts,56.57 it is likely that the 
allografted Ih'er would be susceptible to reinfection and potentially therefore 
to disease. A similar incubation period to the original disease and a preferen-
tial hepatocellular or lobular insult by light microscopy is to be expected. 
Vascular Thrombosis 
The diagnosis of hepatic artery or portal vein thrombosis at this institution has 
large I,· been based on a combination of clinical. operative, sOllographic. and 
radiographic findings. The clinical manifestations range from llliI1lmal effects 
to fulllllll<lnt hepatic necrosis. delayed biliary leak. and relapsing bacteremiaK~D 
Biops~D pathology lllm' or ma~D lIot \'ield a conclusive diagnosis because of the 
variet\' of parenchymal changes seen in association with \'ascular thrombosis. 
Therefore. although biops,' pathology may be helpful in sOllle inst.mces. the 
major contribution of pathology has come from an examination of the remo\'ed 
failed allograft. 
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Figure 14. Adenoviral hepatitis (type 5). Needle biopsy (4 weeks post-transplant) 
with "granulomatous. punched-out" lobular lesion with less hepatocellular necro-
sis than is seen with herpes hepatitis. 
The hepatic artery supplies approximately 30 percent of the oxygenated 
blood to the hepatic parenchyma but is the major source of blood supply to 
the hilar and portal tract structures including the arterial walls, major bile 
ducts, and branches of the portal vein. ;9-62 Therefore with compromise of 
arterial flow one may expect damage to these structures. Also, since the 
allograft is devoid of nerves and most naturally occurring arterial collaterals, it 
may be more sensitive to the effects of arterial compromise. 
The most common post-transplant vascular accident is thrombosis of the 
arterial anastomosis or a major branch of the hepatic artery, occurring in 
approximately 6 to 7 perce'nt of the adult allograft recipients. This occurs 
most often within the first several mont~~splant and quite com-
monly within the first 2 weeks. fso!~_teo-miK~- vei;;' thrombi are much 
less common (two cases) but can be:seenDifi;:e~~Uiation with arterial throm-
bosis. The exact site of initiation of the thrombus is at tImes difficult to 
determine precisely but it: is frequently found near a site of arterial wall 
damage such as a mural su~ure with surrounding granulation tissue, devital-
ized arterial wall, or traumatic mural dissection. ~lostK but not all. thrombi 
seen have been fairly recently deposited as e\'idenced by a lack of extensive 
organization, which in gen~ral reflects the gravity of the clinical situation. 
Others have been extensiv~ly organized suggesting partial compensation of 
the deficient blood supplyi to maintain hepatic function. One young adult 
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male is currently 4 to 5 months posthepatic artery thrombosis and has re-
tained the graft with adequate function. 
Acute cellular rejection may be associated with vascular thrombosis. The 
flow of both arterial and venous blood through the liver slows during rejection 
episodes and there is an increase in intrahepatic pressures. P~ Therefore, when 
acute cellular rejection is occurring 'Within the hepatic parenchyma the possi-
bility of thrombosis at a site of endothelial damage such as a suture line is 
enhanced because of slowed vascular flow. 
Arterial thrombosis may lead to coagulative necrosis of hilar structures as 
would be expected.since tlK!~_ hepatic artery supplies hilar connective tissue, 
the bile ducts, veii1K~~ph nodes. There may be infarction of the 
major bile duce9KS::~ing:to· bile leaks with digestion of the hilar soft tissues, 
explaining the delayed biliary leaks observed clinically. The vein walls may 
also show necrosis and are frequently filled with loosely organized fibrin and 
leukocyte stasis, which may extend into the small venous radicles. The venous 
thrombi seen in association with arterial ones are generally less well orga-
nized, giving an indication as to the sequence of events. 
Pathologic findings within the hepatic lobes may vary considerably from a 
normal appearance to diffuse steatosis, centrilobular hepatocellular balloon-
ing, atrophy or coagulative necrosis, focal or diffuse infarction .. -\.11 of these 
may coexist with cellular rejection of varying degrees. Foci of dystrophic 
calcification in mummified hepatocytes signify previous ischemic damage. The 
remaining viable periportal parenchyma or tissue near infarcts may show 
ductular proliferation accompanied by polymorphonuclear cholangiolitis, "lth 
or without bile stasis similar to that seen in association with operative is-
chemic injury. As mentioned previously, the latter observations may be con-
fused with large duct obstruction v.;th or \\;thout cholangitis. However, in 
ascending cholangitis without ischemic injury coagulative hepatocellular ne-
crosis is not generally observed. l'iecrotic areas on the other hand, often 
become seeded with bacterial and fungal organisms forming abscesses. which 
is not surprising in light of the studies by Brettschneider et aP7 and would 
explain the septicemia seen in these patients. Therefore, stains for micro-
organisms in such a situation may be the first.evidence of a potentially sys-
temic bacterial or fungal infection, and in that respect may be quite helpful. It 
is important to point out, however. that because of an uneven distribution of 
damage throughout the liver, the biopsy process is subject to more sampling 
error than usual. In fact, a small number of biopsies taken when there has 
been documented occlusion of the hepatic artery have shown little to no 
pathologic change. Illustrations of arterial thrombosis and its consequences 
an' shown in Figures 15 and 16. 
Biliary Tract Complications 
Tht' biliary tract has frequl'ntly bet-'ll the site· of complications, i. e., leaks, 
illtrahepatiC' or anastomotic strictures, early or l~te ohstructioll. cholangitis or 
biliary-vascular fistulas, after liver transplantation particularly in e.lrly series 
; 
Figure 15 
bus at the 
from the s 
Subcapsu 
Side of ph 
of patients. 7 , 
failure of sur!! 
ary complicat 
anastomosis s 
duct anastOlTI( 
Y loop. The d 
The earh 
,is and has re-
lrombosis. The 
uring i't,,'Jection 
lerefore, when 
"rna the possi-
suture line is 
r structures as 
'lective tissue 
f:lrction of th~ 
,lr soft tissues, 
ein walls may 
led fibrin and 
s. The venous 
'ss well orga-
erably from a 
ular balloon-
All of these 
If dystrophic 
damage. The 
,5 may show 
.giolitis, with 
operative is-
may be con-
:-Iowever, in 
lcellular ne-
hand, often 
~ssesI which 
and, would 
, for micro-
<:n tially sys-
<: helpful. It 
,tribution of ~D!DD:D" ., •• ' 
re sampling '''':V',, 
n there 'has 
little to no 
:lsequences 
i.e., leaks, 
llangitis or 
·arly series 
i , 
~; 
" 
POST"TRANSPLANT LIVER PATHOLOGY 
Figure 15. Arterial thrombosis. a. Failed allograft specimen with an acute throm-
bus at the site of vascular anastomosis. b,. c. Sections of the major bile ducts 
from the same graft demonstrating necrosis of theKKKKKK:Kdjj~jh bile leakage. d. 
Subcapsular section of the same graft shOWing Air~chymal infarct (left 
side of photo). _ III::II~ c'" - .' 
, 
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of patients. i.8.63-65 The biliaJ'complications were in large part attributed to 
failure of surgical techniques. ~ Accordingly, as techniques improved,66 bili-
ary complications have become less frequent. The preferred type of biliary 
anastomosis seen in this population of patients has been a primary duct to 
duct anastomosis with a T·tube stent or choledochojejunostomy to a Roux-en-
Y loop. The donor gallbladder is removed in both procedures. 
The early postoperative biliary tract complications are usually due to 
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Figure 16. Hepatic artery throm-
bosis. Needle biopsy (1 month 
post-transplant) with ballooning of 
the centrilobular hepatocytes and 
mild ductular proliferation, cholan- ~~~lllllllli~i giolitis, and bile stasis. Note the 
similarity to ~~~i~=:i~~!~~~~~1 The patient retained rebiopsy 5 months DKD~oUDK:fi_; 
only mild portal fi 
trilobular cholestasis. 
technical problems with the surgery or ischemic injury and have been diag-
nosed clinically or by radiologic procedures. 63-63 Biopsy pathology in these 
instances has not been the major means of diagnosis; however, when access to 
the biliary tree is not readily available it may provide useful information in 
gUiding further investigative or therapeutic procedures. 
Changes related to large duct obstruction (total or partial due to strictures), 
acute cholangitis, and biliary-vascular fistula formation are the most frequent 
complication recognized histopathologically. The morphologic changes asso-
ciated with these complications are identical to those in nonallograft livers. H .15 
Pathognomonic changes of large duct obstruction in biopsy specimens which 
may take up to a week of total obstruction to develop14.67 are not frequently 
seen since prompt clinical recognition and surgical correction of this problem 
is essential. 7 In fact, intraoperative biopsies obtained dUring an operative 
revision of an obstructed biliary anastomosis have in some instances failed to 
show evidence of duct obstruction. Nevertheless, several histopathologic find-
ings can be used to identify ductal obstruction or cholangitis and to distin-
guish it from rejection. The most useful criteria for recognizing large duct 
obstruction and cholangitis are identical to those outlined by Gall and 
otherslU5.67 and include bile lakes; suppurative cholangitis: dilated, prolif-
erated, and tortuous ducts with periductal edema and peri ductal lamellar 
fibrosis. The predominantly pol~·morphonuclear nature of the portal infiltrate 
with the presence of neutrophils \vithin the wall and lumen of bile ducts with 
periductal edema is particularly helpful in differentiating early duct obstruc-
tion or cholangitis from rejection in which the infiltrate has a hi~her content of 
mononuclear cells .. \ugmented immunosuppre~ive therapy given before ob-
taining a biopsy alters the morphology and therefor!:' adds to the confusion 
,see discussion of partially treated rejection). SuppuratiH' choi.mgitis when 
severe may lead to duct damage. destruction, and focal abscess formation: 
Bile and blood cultures may be helpful in idcntifyin!! patho~enic organisms in 
these instances. Howt;'\'er, bile cultures from T -t'ube drainage mar be positive 
for cnterit' hacteria without clinical or pathologit~ e\'idt'nce of sepsis or ('holan-
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gitis. l'nfortunately, in some instances, the pathologic nll(lings tlla~D not he 
diagnostic out only be su~gestiyDe of duct obstruction or cholangitis. Further 
assessment of the clinical situation or diagnostic tests stich as chobngiogratlls 
or ultrasonography must be then performed. 
Bilian'-\'ascular fistula formation occurred in three instances and demon-
strated quite inconspicuous histopathologic findings if one were not attuned to 
the abnormal presence of red blood cells within bile ductules. 
Later biliary tract complications (>6 monthsi are usually related to estab-
lished graft pathology such as arterial compromise and intra- or extrahepatic 
biliary strictures associated with cholangitis. Although strictures at the opera-
tive anastomosis are not entirely unexpected. those occurring in the hepatic 
parenchyma, some of which are associated \\ith biliary sludge, are more diffi-
cult to explain. 
Late onset (>6 months) intrahepatic bile strictures associated \\ith biliary 
sludge were much more common before adopting as the preferred type pri-
mary duct-to-duct biliary anastomosis. &1-66.68 Since the switch from cholecys-
toduodenostomy to choledochocholedochostomy as the procedure of choice. 
the incidence of intrahepatic bile sludge has decreased dramatically:,66 but has 
been seen in one pediatric patient. The biopsy features were those of biliary 
obstruction (Fig, 17). 
Three other patients have developed delayed onset intrahepatic stric-
tures. Evidence of chronic rejection with severe vascular lesions and superim-
posed thrombosis with multiple intrahepatic abscesses was present in one 
Figure 17. Duct obstruction/cholangitis. Needle biopsy (7 weeks post·transplant) 
with large duct obstruction. Changes of duct obstruction in the allograft liver are 
identical to those seen in nongrafts (see text). Note the bile plugs, mildly prolifer-
ated ducts and acute cholangitis (inset). 
• 
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patient at autopsy (see section on Chronic Rejection) .. \nother patient was 
found to have a thrombosed hepatic artery, which was thought to contribute 
to or cause the strictures .. \ third patient. whose original disease was scleros-
ing cholangitis, developed intrahepatic biliary strictures documented by chol-
angiography. However, the extrahepatic biliary tree was relatively spared in 
contrast to the patient's original disease. In a series of four percutaneous 
biopsies obtained over a period of 1 year, there was progressive portal fibro-
sis; ductular widening and proliferation; mild cholestasis; and, in the last 
biopsy, a single lymphogranulomatoid inflammatory aggregate near btlt not 
'im'olving a septal duct (Fig. 18). There was minimal portal inflammation 
otherwise. The graft is still functional at this time which precludes a more 
detailed examination of the organ to determine the possible cause of the 
strictures. Although recurrent disease is possible, many confounding factors 
such as ischemic injury make such a diagnosis impossible to confirm. 
Recurrent Original Disease 
The possibility of recurrent primary disease is of prime consideration in the 
field of transplantation. Documented recurrences of the original disease in 
adult patients studied at this institution include eBI~S9 hepatic malignan-
cies. 70.71 and the Budd-Chiari syndrome. 72 Reported recurrences at other 
institutions in addition to HE and hepatic malignancies include primary bili-
ary cirrhosis (PBC)73 and "autoimmune" hepatitis. T~ Recurrence in the pediat-
ric population has not been a problem to date, except for an instance of 
neuro\'isceral storage with ophthalmoplegia,73 in which there was recurrent 
deposition in the new liver and progressive neurologic disease. In fact a 
number of metabolic disorders ha\'e been "cured," by transplantation: alpha-
I-antitrypsin deficiency, \Vilson's disease, tyrosinemia, cholesterol LDL re-
Figure 18. Late onset intrahe-
patic strictures. Needle biopsy (1 
year post-transplant); the pa-
tient's original disease was scle-
rosing cholangitis. Note the para-
ductal lymphoid aggregate and 
portal fibrosis (see text). 
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ceptor deficiency, glycogenosis types 1 alld -1. and Factor VIII-deficil'lIt 
hemophilia. 76-7S 
Although HB, malignancies. and Budd-Chiari syndrome are not difficult 
to differentiate from rejection or complications arising as a result of transplan-
tation, the same cannot be said of PBC, non-:\.. non-B hepatitis. or sclerosill!!; 
cholangitis. The difficulty arises because of the apparent pathophysioIOl. .. 'it' 
similarities of PBC and chronic rejection, KC9-~~ the lack of a specific marker 
for non-A, non-B hepatitis and the problem with postoperative biliary stric-
tures for sclerosing cholangitis. 
Neuberger et aFl reported the recurrence of PBC in three patients 
post-transplantation based on the characteristics of the clinical course. reap-
pearance of elevated serum titers of antimitochondrial antibodies. and the 
presence of granulomas and increased copper deposition in needle biopsies 
obtained from those patients. It is of note that the recurrences were docu-
mented 3 to 4 years after the procedure. :\ detailed analysis of 19 patients 
with PBC as the primary diagnosis in whom tissue specimens were available 
(from 2 months to 4 years post-transplant). has failed to show a recurrence 
based on the aforementioned criteria. It is of note. however, that only three of 
the patients have tissue samples after 2 years. All of the patients had recur-
rence of elevated titers of antimitochondrial antibodies; however. none of the 
patients developed pathologic of clinical manifestations of recurrent PBC. 
Histopathologic features of end stage PBC were compared to those seen in 
chronic rejection in failed allografts from patients with and without PBC as 
the original disease. The similarities and differences are shown in Table -t-
If the pathogenesis of PBC is indeed an autoimmune disease with cell-
mediated cytotoxicity directed at self-~f HC or other biliary antigens, P4KTgK~1KUO 
changing the target organ should have some effect on the recurrence of the 
pathogenic sequence unless the originally recognized biliary or ~feC antigens 
are present in the graft. Also. since the allograft rejection reaction may in-
volve destructive immunologic mechanisms similar to PBC,34.82 separation of 
the two processes may be quite difficult. Further confounding the analysis is 
TABLE 4. HISTOPATHOLOGIC COMPARISON OF END STAGE PBC AND 
CHRONIC REJECTION Zcc"- . 
End ptage"m:Uc;:~::Cbronic Rejection 
Granulomas 
Lymphoid nodules 
Loss of ducts 
Cholestasis 
Copper deposition 
Cirrhosis 
Marginal ductular proliferation 
Chronic vascular lesions 
Lobular foam cells 
Mallory's hyaline 
+ 
+++ 
+++ 
+ + ipenpheral 
++ 
+++ 
++ 
+ 
+ 
"Minimal depoSItion seen in occasional centrilobular hepatocyte. 
+ 
+++ 
++/central 
-/+. 
+/-
++ 
+1++ 
'\ , 
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the fact that other antigen systems (foreign .MHC and endothelial) are intro-
duced with the graft making superimposed rejection changes likely. The 
possibility of an "overlap" syndrome of rejection and recurrent PBC or accel-
erated duct destruction in PBC patients whose immune system may be sensi-
tized to biliary antigens cannot be disregarded. 
We previously suggested the potential difficulty in separating non-A, 
non-B hepatitis from chronic allograft rejection, especially in light of the 
reports of the presence of bile duct lesions in the former. 36,57 Although separa-
tion of the two proce$Ses f1}~not always be possible, the presence of promi-
nent lobular alterations-in nepaWis similar to those caused by the B virus may 
be helpful. Also, tl.!.e:bile=ttuct lesions described in non-A, non-B hepatitis 
appear to more frequently involve medium-sized ducts associated \l.1th a lvm-
phoid nodule, and are reported to be less prevalent and less widespread, i.e., 
involVing fewer bile ducts, than in rejection, Duct loss similar to that seen in 
chronic rejection has not been described for chronic viral hepatitis. 
Drug Toxicities 
The essential criteria used for identification of adverse drug reactions (ADR) 
were summarized by lrey83 and he presented an algorithm for the application 
of these criteria. Irey pointed out that "the disease indicator of an ADR 
should be chosen such that it is not affected by either the basic disease of the 
patient or by any concurrent comorbid state." One quickly realizes that strict 
application of this method is particularly difficult in the liver transplant pa-
tient when biochemical and morphologic indicators of liver injury are used as 
the disease marker of an adverse drug reaction (ADR). 
Presently, the diagnosis of an ADR is only rarely based on the histopatho-
logic findings present in a liver allograft biopsy. 
The histopathologic manifestations of specific hepatotoxic drug reactions 
are reviewed in detail elsewhere24 and only those agents which are likely to 
play a major role in such reactions in liver allograft patients are discussed, 
Cyclosporine (Cys) is knO\\l1 to be hepatotoxic in renal, b.j bone marrow. 55 
heart,86 and liver transplant patients27 as well as in nontransplanted indi\'iduals 
who receive this drug. ~lost studies report modest hyperbilirubinemia with 
mild elevations of the transaminases which uniformly resol\'ed after a lowering 
of the dosage, Cnfortunately, all of these studies are based on biochemical 
e\-idence of liver dysfunction coincident with elevated blood le\'els of crdo-
sp0rine with no mention of hepatic morphology. Therefore. information about 
the structural alterations which may be secondary to the drug is limited to 
indi\'idual case accounts and animal studies. 57 Histopathologic findings in hu-
m;U1S which ma\' have been secondary to C\'s toxicit\' include cholestasis and 
random acidopl~ilic degeneration of hepato~~tesI ~T Centrilobular steatosis in 
addition to the above findings have been reported ,in animal studies, ,7 
Clinical\\', Cys is notorious for its adverse affect on renal function, which 
along with blood levels and clinical symptomatlllohTY sen'e as guides for thera-
pcutic monitoring. 
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Glllcocorticoids are kno\\'l\ to induce hepatic ste~ltlgpis in man~1 eV(.'1l ill 
relatively small doses (15 to 29 ing prednisone/day). The dfccts of much larger 
doses stich ,IS those recei\'ed b;· transplant patients immediately after sur)..;cry 
and for treatment of cellular rejection are unknown. However, man is re-
ported to be a "relatively glucocorticoid-resistant" speci(.'s, ':3,;:(; Animal studies 
on the effect of glucocorticoids on hepatic function and morphology confirm 
that high doses administered ito rabbits. rats. dogs, and mice can produce 
ballooning, vacuolization. glycogen accumulation. and local necrosis (in rab-
bits).23,16 \Vhether a similar effect can be seen in man is uncertain and further 
studv is necessar\", 
:-\zathioprine' and other cytotoxic drugs haw been olssociated with "veno-
sclerosis" within the liver. s.s One must therefore be ,m:are of the potential 
hepatotoxic side effects of patients receiving these drugs as part of the immu-
nosuppressive regimen. 
Other therapeutic agents ha\'e been reported to produce histopathologic 
changes which may appear similar to immunologic or infective complications 
seen in allograft biopsies. Reference to texts dealing \I.;th this subject is 
suggestedKl~ 
Hyperalimentation , 
The morbidity associated with'the surgery may necessitate prolonged periph-
eral alimentation which may produce structural alterations within the liver, 
which are not significantly different from those described in non graft livers, ,9 
The changes include hepatocinalicular cholestasis, cholangiolar proliferation 
with ductal cholestasis, steatosis. pigment deposition. and sinusoidal fibrosis. 
It is important to recognize the changes so that the alterations are not im-
puted to other processes. 
THE ROLE OF LIVER BIOPSY IN PATIENT CARE 
The liver biopsy has come to playa vital role in patient management during 
the postoperative clinical course. Not uncommonly, a specific diagnosis for a 
cause of graft dysfunction can· be rendered. which rna)" w:.'may not have been 
clinically apparent. Alternatively. hiirless frequently,....a-c1inical diagnosis of 
graft dysfunction may be apparent witnout p"athEFg~rmationK ~fost fre-
quently, the two are in agreement. - - .. 
Although the biopsy findings are reliable and can be used to gUide ther-
apy and other diagnostic procedures, one must be aware of the limitations of 
the procedure. \fany if not all of the limitations of allograft biopsy are identi-
cal to those outlined many years ago for liver needle biopsies in general. 90 The 
liver may react nonspecifically to a variety of noxious stimuli. This shortcom-
ing is particularly evident when attempting to diagnose drug toxicities in 
these patients in whom so many other factors are involved which may lead to 
similar if not identical histologic alterations. Another is the focal nature of 
ilia 
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some of the graft syndromes described previously which may lead to sampling 
problems. This is particularly evident in early rejection which may be quite 
focal-focal subcapsular infarcts, intrahepatic abscesses, or the changes asso-
ciated with vascular thrombosis. Also, graft dysfunction which may be detect-
able by other means may not be demonstrated histopathologically, such as 
bile duct or vascular obstruction, especially if it is partial or of short duration 
before biopsy. Perhaps the most significant limitation, which is a consequence 
of the factors mentioned above, is the rate of false-negative findings on biopsy 
specimens. AlthougC-:D~i!IieK not. statistically evaluated the frequency of 
occurrence of false-negative 'findings,. they are not rare. In these instances, 
review with the clinical-physician is invaluable. 
CONCLUSIONS 
This review was intended as a general guide to the interpretation of the 
morphologic representations of the !Jathophysiologic events that occur in the 
liver after transplantation. We are far from understanding all the various 
lesions that are seen in biopsy specimens, particularly those occurring years 
after the procedure since experience with these types of specimens is limited. 
Also, knowledge of the impact of the primary disease on the postoperative 
course is limited. However, we hope this review will prove useful to those 
pathologists faced with interpretation of post-transplant liver pathology. 
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